Related by context. All words. (Click for frequent words.) 65 Consensus Statement 65 Position Statement 60 Guidance Document 59 Consultation Document 59 Situational Analysis 58 Ethical Guidelines 58 Improving Outcomes 58 Issues Relating 57 Issue Brief 57 Stakeholder Workshop 57 Concluding Observations 57 Expert Advisory Panel 57 Environmental Impacts 57 Clinical Guideline 57 Stocktaking 57 Comprehensive Approach 56 Striking Balance 56 Clinical Practice Guideline 56 Transatlantic Agenda 56 Regulatory Developments 56 Issues Surrounding 56 Discussion Document 56 Strategic Approach 56 Emphasizes Need 56 Voluntary Guidelines 56 Counterfeit Drugs 56 Periodic Review 56 Discussion Paper 55 FLEG 55 Balanced Approach 55 Strategic Framework 55 Urges Immediate 55 Misconceptions About 55 Spending Priorities 55 Preventing Medication Errors 55 Trade Liberalization 55 Regulatory Framework 55 Unsafe Abortion 55 Musculo Skeletal Disorders 55 Ethical Considerations 55 Policy Framework 55 Panel Faults 54 Evolving Role 54 Hazardous Drugs 54 Clinical Practice Guidelines 54 Pesticide Residues 54 Preliminary Findings 54 Structural Reform 54 Monograph 54 Policy Statement 54 Holds Workshop 54 Gender Differences 54 Investigational Drugs 54 Microbial Threats 54 Proposed Changes 54 whitepaper entitled 54 Attitude Towards 54 Governance Structure 53 Impact Assessments 53 Annan Urges 53 Cites Flaws 53 Practitioner Guide 53 Better Outcomes 53 Workplan 53 Specification PAS 53 Monographs 53 Universal Periodic 53 Medication Adherence 53 Accountancy Profession 53 Selection Criteria 53 Adverse Effects 53 Empower Yourself 53 #-# Full Text 53 Psychotropic Drugs 53 Political Interference 53 Stakeholders Workshop 53 Successful Outcome 53 Regulatory Regime 53 Future Directions 53 Informal Economy 53 Challenges Faced 53 Data Exclusivity 53 Fact Sheet 53 Data Indicate 53 Clinical Efficacy 53 Perception Survey 53 Vaccine Immunology 53 Regulatory Frameworks 52 Inches Towards 52 Add.1 52 Potential Dangers 52 entitled Formulary Advantages 52 Concise Guide 52 Untapped Potential 52 Holistic Approach 52 Tackling Climate Change 52 Framework Directive 52 Practice Guideline 52 document A/#/# [002] 52 Urgent Appeal 52 Students Studying Abroad 52 Stakeholder Meeting 52 Regulatory Toxicology 52 ACCF AHA 52 Collaborative Approach 52 Strategic Priorities 52 Advises Caution 52 Judicious Use 52 Risks Posed 52 Alternative Approaches 52 Systematic Review 52 Cancer Incidence 52 Interoperability Standards 52 Harmonization Task Force 52 Issues Raised 52 Study Shows Benefits 52 Toxicity Testing 52 Latest Developments 52 Ethnic Disparities 52 Common Pitfalls 52 Myths Realities 52 Antiretroviral Drug 52 Corporate Governance Practices 52 Sounds Alarm 52 Success Depends 52 Negative Effects 52 Female Genital Mutilation Cutting 52 Disclosure Requirements 52 Respirology 52 Outlines Priorities 52 Comparative Effectiveness 52 Unequal Treatment 52 Must Reject 52 Emphasizes Importance 52 Abdominal Obesity 52 Reforms Needed 52 Fishing Vessels 52 Deepening Crisis 52 Challenges Confronting 52 Progamme 51 Growing Importance 51 Draft Outcome Document 51 Gender Inequality 51 Statement 51 Export Controls 51 Biotech Crops 51 Increased Incidence 51 Pension Reforms 51 Treating Depression 51 Practical Approach 51 Consultation 51 A/#/# [001] 51 Terrorist Offences 51 Promulgation 51 Sensitised 51 Arterial Hypertension 51 Experts Urge 51 Ministerial Statement 51 Steps Toward 51 Drug Importation 51 Quadrivalent 51 Urgent Need 51 Seasonal Influenza Vaccine 51 Guidelines Issued 51 Poverty Inequality 51 journal Systematics 51 Multiple Myeloma Patients 51 Climatic Changes 51 Alternative Treatments 51 Psychological Effects 51 Preventive Measures 51 Low Carbon Economy 51 Reasonable Accommodation 51 Securing Cyberspace 51 Perinatal Mortality 51 Improve Diagnosis 51 Potential Impacts 51 Same Sex Relationships 51 Poses Risk 51 Pregnancy Outcomes 51 Nutrition Labels 51 Stricter Rules 51 Herbal Medicines 51 Study Proves 51 Seeks Input 51 Electronic Prescribing 51 Revised Guidelines 51 Thematic Strategy 51 PDF #KB [001] 51 Meta Analysis 51 Challenges Ahead 51 Improving Patient Safety 51 Framework 51 Resubmission 51 Gastrointestinal Disorders 51 Changing Role 51 Applauds Introduction 51 Biggest Obstacle 51 Policies Affecting 51 Play Crucial Role 51 Prognostic Factors 51 Clin Trials 51 Fight Against Corruption 51 document A/#/#/Add.# 51 Laryngeal Cancer 51 Trademark Litigation 51 Yogyakarta Principles 51 Interoperability Framework 51 Food Labelling 51 Report Indicates 51 TB Vaccine 51 Invasive Fungal Infections 51 Tax Havens 51 Holds Seminar 51 Pharmacoepidemiology 51 Ministerial Declaration 51 Therapy Shows Promise 51 Coronary Revascularization 51 Expert Discusses 51 Strongly Supports 51 Homosexual Persons 51 Cooking Microwave Popcorn 50 Factsheet 50 Water Fluoridation 50 Ethical Aspects 50 Study Reinforces 50 Regulatory Issues 50 Pluripotent Stem Cells 50 Clinician Guide 50 Skills Shortage 50 Talks Deadlocked 50 RISDP 50 Forced Migration 50 Functional Outcomes 50 Endocrine Practice 50 Avoiding Pitfalls 50 E/CN.#/#/# 50 Recommended Practices 50 Combating Counterfeit Drugs 50 Be Addressed 50 Religious Persecution 50 Multi Stakeholder 50 Earmark Reform 50 Effort Needed 50 Challenges Facing 50 Root Causes 50 Differential Diagnosis 50 Webinar Focuses 50 Wonca 50 Decision Making Process 50 Expert Opinion 50 Innovative Approaches 50 Venous Thromboembolism 50 Critical Juncture 50 Childhood Immunizations 50 explanatory memoranda 50 Genes Linked 50 Preterm Birth 50 Pneumococcal Disease 50 Misinformation Campaign 50 Transparency Initiative 50 Shedding Light 50 Preferential Treatment 50 Dispelling Myths 50 Treating Chronic 50 Racial Disparities 50 Solemn Declaration 50 Biological Effects 50 Preventing Childhood Obesity 50 Reduces Mortality 50 Reaffirms Support 50 Interpretive Guidance 50 Relationship Between 50 Randomized Controlled Trials 50 Association EHRA 50 Pastoral Letter 50 GHTF 50 Diet Physical Activity 50 Nondiscrimination 50 Ethnic Differences 50 Proton Pump Inhibitors 50 Diet Supplement 50 SHIRE PLC 50 Miscellaneous Amendments 50 Medication Errors 50 Critical Component 50 Core Principles 50 Cooperation Framework 50 Intensive Care Medicine 50 Antibiotic Use 50 GRI G3 50 Chemical Contamination 50 Comparative Analysis 50 AMVETS Disabled American 50 Folic Acid Fortification 50 Antimicrobial Resistance 50 Humanitarian Situation 50 Issues Impacting 50 Proposed Revisions 50 Iron Deficiency Anemia 50 PhRMA Code 50 Whistleblower Protection 50 Debate Rages 50 Drug Approvals 50 Shared Responsibilities 50 Analytical Methods 50 #:#-#,# Abstract Free 50 Panel Mulls 50 Must Rethink 50 Inhaled Liposomal Ciprofloxacin 50 Multilateral Cooperation 50 Essential Element 50 Reducing Poverty 50 Factsheets 50 NCJ # 50 Reducing Underage Drinking 50 SmPC 50 Practice Guidelines 50 Cardiovascular Interventions 50 Health Inequalities 50 Underlies 50 Rural Dwellers 50 Enlargement Strategy 50 EGTT 50 Environmental Degradation 50 Panel Examines 50 Stable Angina 50 Prescriber 50 Combating Climate Change 50 Occupational Exposure 50 Conceptual Framework 50 Preterm Labor 50 Cervical Spine 50 Deeply Concerned 50 Expert Panel 50 Arbitration Agreements 50 Epilepsia 50 Zoonoses 50 whitepaper titled 50 Panel Urges 50 Regulatory Impact Statement 50 Drug Resistant Tuberculosis 50 Publicly Funded 50 Federal Preemption 50 Publicly Available 49 Alarming Rise 49 EMBO Molecular Medicine 49 Child Mortality 49 Highlights Importance 49 Gynecologic Cancers 49 Organizations Urge 49 Economic Impacts 49 Myths Debunked 49 Fetal Pain 49 Implementation Agreements 49 Generic Pharmaceutical 49 EHPM 49 EP Plenary 49 Recommends Changes 49 Trade Offs 49 Awareness Campaigns 49 Vulnerable Populations 49 Hidden Epidemic 49 Screening Tool 49 Data Suggest 49 Structural Reforms 49 Ministerial Consultation 49 Shows Efficacy 49 What Constitutes 49 CGPCS 49 Biodiversity Assessment 49 J Pediatr 49 A/#/# [002] 49 Raises Doubts 49 Regulatory Flexibility 49 Evidenced Based 49 Experts Advise 49 Policy Implications 49 Antidepressant Treatment 49 Issues Guidance 49 Practical Steps 49 Organisa tion 49 Total Hip Replacement 49 Therapeutic Potential 49 Childhood Vaccinations 49 Noncommunicable Disease 49 Attitudes Towards 49 Study Concludes 49 Outlines Steps 49 Informed Choices 49 Creates Opportunities 49 Implications 49 Comparative Study 49 Report Sheds Light 49 A/C.#/#/L.# 49 Expresses Concern About 49 Genetically Engineered Animals 49 Seriously Flawed 49 Screening Mammography 49 Trans Fatty Acids 49 Diagnostic Criteria 49 Study Sheds Light 49 Process Validation 49 Voices Concern 49 Authorized Generics 49 Copenhagen Diagnosis 49 Inflammatory Arthritis 49 Removing Barriers 49 Highlight Importance 49 Deplores 49 Surgical Infections 49 RES# [001] 49 Female Genital Cutting 49 Pressure Ulcers 49 Organisational Change 49 Constantly Changing 49 Debunking Myths 49 Expert Urges 49 Clinical Trial Data 49 Decision #/#/EC 49 Neck Pain 49 Steps Towards 49 Casts Doubts 49 Urgent Issues 49 Alternative Medicines 49 Strengthen Cooperation 49 Adopts Resolution 49 Revised Recommendations 49 Research Protections OHRP 49 Conducting Clinical Trials 49 Sniffing Dogs 49 Harmonise 49 Decries Lack 49 Cell Differentiation 49 Stocktake 49 Crisis Threatens 49 Acute Pain 49 Diagnostic Tests 49 H#N# Pandemic 49 DG SANCO 49 Randomised Controlled Trial 49 Continuous Disclosure 49 Strategy Report INCSR 49 Protective Measures 49 Recognize Excellence 49 Actions Taken 49 Religious Belief 49 Disruptive Behavior 49 Growing Problem 49 Action Plan 49 Applicant Guidebook 49 Globalized World 49 Consultative Process 49 Setting Priorities 49 GASB Issues 49 Low Carbon Future 49 Practises 49 Interrogation Techniques 49 Legislative Agenda 49 Therapeutic Approaches 49 EC Directives 49 Öko Institut 49 Cost Avoidance 49 Implication 49 Move Towards 49 Reiterates Support 49 Decolonisation 49 Governance Framework 49 Preventing Genocide 49 Expert Advises 49 Gender Mainstreaming 49 Biodegradable Polymers 49 Systematic Approach 49 Periodontal Disease 49 Antitumor 49 Regulations Governing 49 Myths Surrounding 49 Antipsychotic Drug 49 Study Examines 49 Donor Organs 49 Urgently Needed 49 Significant Contribution 49 communiqu 49 Consultation Paper 49 Prevent Suicides 49 Asthma Medication 49 #:#-# [019] 49 Garnaut Climate Change 49 Accelerating Clinical Trials 49 Mashelkar Committee 49 Safe Medication 49 Contraceptive Use 49 Meth Epidemic 49 Releases Findings 49 Ann Emerg Med 49 Procedural Rules 49 Reduced Risk 49 Textile Quotas 49 Xenotransplantation 49 Gendering 49 Spinal Manipulation 49 Expresses Concern 49 Therapeutic Intervention 49 Combating Money Laundering 49 Topical Treatment 49 Taxonomic 49 Conventional Arms Transfers 49 Report Outlines 49 Organizational Chart 49 Cardiovascular Risk Factors 49 Agenda 49 IIFB 49 Racial Diversity 49 Disaster Situations 49 Partisan Politics 48 Artificial Cornea 48 Helping Smokers Quit 48 Renal Transplantation 48 Assessment Methodology 48 Clinical Outcome 48 Trade Liberalisation 48 Pendulum Swings 48 Drastically Reduced 48 Vitamin D Deficiency 48 Outlines Strategies 48 Review Mechanism 48 Promoting Gender Equality 48 Roadmap 48 Hormonal Therapy 48 Early Diagnosis 48 Peer Reviewed Journal 48 Impact Assessment 48 Asthma Inhalers 48 Legislative Priorities 48 PLoS Neglected Tropical Diseases 48 Occasional Paper 48 Indoor Radon 48 Deeply Concerned About 48 Meningitis Vaccine 48 Ethical Dimensions 48 Human Embryo 48 Gender Responsive 48 Steep Rise 48 Climate Impacts 48 Tightens Rules 48 Food Additives 48 #:#-#,# [002] 48 Job Vacancy 48 #:#-# [037] 48 Path Toward 48 #KB PDF 48 Childhood Overweight 48 Untapped Resource 48 Emissions Reductions 48 Proposed Rule Changes 48 Genetically Engineered Foods 48 Concerns Raised 48 Policy Makers 48 Scaling Up 48 Chemical Substances 48 Seminar Focuses 48 Statin Drugs 48 Molecular Basis 48 Stresses Importance Of 48 Practioners 48 Panel Advises 48 Multidrug Resistant 48 Ecosystem Approach 48 Musculoskeletal Disorders 48 Sector Reforms 48 Prenatal Exposure 48 Deskbook 48 Chronic Lyme Disease 48 POPRC 48 HCV Protease Inhibitor 48 Analytical Method 48 communiquÈ 48 Injectable Drug 48 Influenza Pandemic 48 Tort Liability Law 48 Smallpox Vaccination 48 Double Edged Sword 48 Official Warns 48 Negative Consequences 48 Adverse Events 48 Statutory Instruments 48 Ecodesign 48 Asean Intergovernmental 48 Phytotherapy Research 48 Protein Linked 48 Seeks Clarification 48 Critical Appraisal 48 Official Praises 48 #:#-#,# CrossRef Medline [002] 48 Report Suggests 48 Growing Epidemic 48 Double Taxation Agreements 48 Electromagnetic Fields 48 Preterm Delivery 48 Postmarket 48 Illicit Drug Use 48 Misleading Claims 48 Relation Between 48 Authoritative Guide 48 Programmatic Environmental Impact Statement 48 Statistical Yearbook 48 Best Practice Guidelines 48 Overviews 48 Viable Alternative 48 Advocacy Groups 48 Ensure Compliance 48 Moving Towards 48 Approach Needed 48 Antiretroviral Treatment 48 Poses Challenge 48 Strongly Linked 48 Enhancing Competitiveness 48 Empirical Evidence 48 Prescription Medicines 48 Corporate Governance Principles 48 #:#-#,# Medline 48 Implementers 48 Restoring Confidence 48 Envoy Calls 48 Misperception 48 Renal Tumors 48 Interdependent 48 Makes Recommendations 48 Study Explores 48 Workplace Relations Amendment 48 Enforced Disappearances 48 Accountability Responsibility 48 Raises Concerns About 48 Challenges Remain 48 Erythropoietic 48 Climate Change Mitigation 48 Innovation Imperative 48 Holds Hearing 48 Regulatory Requirements 48 Powerful Tool 48 Concerns Remain 48 Formal Request 48 Integrated Approach 48 Performance Benchmarks 48 Fact Sheets 48 Regulatory Bodies 48 Stresses Need 48 Stakeholder Forum 48 BizAcumen LLC 48 Protection ICNIRP 48 Prolongs Survival 48 Tertiary Education Strategy 48 #:# -# Abstract Free [001] 48 Sustained Release 48 Efficiency Effectiveness 48 Smallpox Vaccination Program 48 Gender Discrimination 48 Unfinished Agenda 48 Experts Weigh 48 Privacy Breaches 48 Groups Warn 48 Source Fasken Martineau 48 Election Manifesto 48 Outlines Goals 48 Cognitive Functioning 48 Issues Remain 48 SCENIHR 48 Osteoarthritis Patients 48 #:#-# [040] 48 Lobbying Effort 48 Econ Crisis 48 Organisational Structure 48 Crucial Role 48 Neoplasia 48 Hong Kong Ministerial Declaration 48 Poses Serious 48 Overcoming Barriers 48 Opinion Piece Says 48 Motorized Travel 48 Nurse Shortage 48 Colorectal Screening 48 Surgical Procedures 48 Semi Autonomous 48 Missed Opportunity 48 Hematological Cancers 48 Strategy 48 Could Harm 48 AFEP MEDEF 48 Study Analyzes 48 Smallpox Vaccine 48 Urgent Measures 48 Approval Process 48 SADC Principles 48 Practical Application 48 Pandemic Influenza Preparedness 48 Organization ITTO 48 Early Psychosis 48 Raises Concern 48 Counterfeit Medicines 48 Armed Conflicts 48 Influenza Pandemic Preparedness 48 Towards Sustainable 48 Stresses Importance 48 Textile Quota 48 Coding System 48 Population Projections 48 Technical Barriers 48 Antithrombotic 48 Report Cites 48 Regulator Seeks 48 Compliance Statement 48 Competency Model 48 Commissioner Vladimír Špidla 48 Reduce Mortality 48 Hepatitis Virus 48 Essential Requirements 48 Adverse Outcomes 48 Breast Carcinoma 48 Reference Document 48 Innate Immunity 48 Racial Disparity 48 Motor Vehicle Crashes 48 Process Automation Solution 48 Structural Imbalance 48 Urine Test 48 Precondition 48 FDA Panel Recommends 48 Impediment 48 Anti Clotting Drug 48 Biosurveillance 48 Guidelines 48 Faces Shortage 48 Clinical Evaluation 48 Categorisation 48 Dental Amalgam 48 Releases Podcast On 48 Pharmacologic Treatment 48 Urges Caution 48 Could Disappear 48 Announces Publication 48 Combating Poverty 48 Appears Safe 48 Multilateral Trade 48 Focuses Attention 48 Cooperation Treaty 48 Issues Addressed 48 Practice Recommendations 48 Mitigate Risks 48 Non Compliant 48 User Requirements 48 Declared Unconstitutional 48 Tougher Stance 48 theAmerican Journal 48 Nuclear Watchdog 48 Guidelines Recommend 48 Expedited Review 48 article #.#/NEJMoa# 48 Mitigating Climate Change 48 Report Assesses 48 Organ Trafficking 48 Thrombolytic Therapy 48 Negotiators Agree 48 Helps Ensure 48 Pandemic Preparedness Plan 48 Urges Stronger 48 Practical Applications 48 Ethnic Groups 48 Physical Examination 47 Trillion Reasons 47 Leaders Convene 47 Domain Name Dispute Resolution 47 Argument Against 47 Leaders Warn 47 Renal Failure 47 Groups Condemn 47 report1 47 Blood Clotting 47 Critical Perspectives 47 Pesticide Exposure 47 Organiza tion 47 Hidden Costs 47 Missed Opportunities 47 Adjuvant Chemotherapy 47 Consultation Conclusions 47 Mortality Risk 47 TITLE File Inclusion 47 Views Differ 47 #:#-#,# [003] 47 Guideline 47 Panel Discusses 47 Conflicting Interests 47 Remains Elusive 47 Govt Urged 47 NUREG 47 Subsidiary Body 47 Income Inequality 47 @ Gowlings 47 Warrantless Surveillance 47 Non Communicable Diseases 47 Strategic Plan 47 Helps Identify 47 Bacterial Infection 47 Transparency Accountability 47 Doha Declaration 47 Indicator Survey 47 Publishes Article 47 Legislation Passed 47 Transparent Governance 47 HIV AIDS Epidemic 47 Protein Synthesis 47 Human Heredity 47 Sectorial 47 Preventing Chronic Disease 47 Raises Doubts About 47 Schizophrenia Treatment 47 Endocrine Disruptors 47 Study Indicates 47 Genetic Diversity 47 Antiviral Drugs 47 Competiveness 47 Practical Guide 47 Intricacies 47 Common Misconceptions 47 Practical Implications 47 Greenhouse Gas Inventory 47 Demonstrates Sustained 47 Proves Effective 47 Communiqué 47 Approves Sweeping 47 Pros Cons 47 International POPs Elimination 47 Rapporteurs 47 Treatment Approaches 47 Agreed Principles 47 Product Monograph 47 Postcolonial 47 Quality Indicators 47 NHHRC 47 Practical Aspects 47 Hidden Danger 47 Compelling Case 47 Effectively Treats 47 FDA Cracks Down 47 Appropriateness Criteria 47 Makes Headway 47 Illicit Drug 47 Adult Acne 47 Debate Heats Up 47 Structural Changes 47 Breach Notification 47 ICESCR 47 Approvable 47 JPOI 47 Cardiovascular Outcomes 47 Deaths Prompt 47 Sexual Behaviors 47 Anti Terrorism Measures 47 Platelet Function 47 Accounting Practices 47 Critical Shortage 47 Clinical Significance 47 Extractive Industries 47 Tackling Corruption 47 Molecular Pathogenesis 47 Carries Risks 47 Bird Flu Pandemic 47 Emissions Targets 47 Job Descriptions 47 Counter Terrorism Strategy 47 Priority Areas 47 Pandemic Influenza Vaccines 47 Panel Finds 47 Moral Responsibility 47 Requires Immediate 47 Stem Cell Treatment 47 EFSA Panel 47 Restricts Access 47 Genes Identified 47 Could Save Lives 47 Issue Heats Up 47 Religious Fundamentalism 47 Passes Resolution 47 Vastly Different 47 Going Smoothly 47 Imperiled Species 47 Failing Grades 47 Self Assessment Tool 47 See CLINICAL PHARMACOLOGY 47 Guiding Principles 47 Pandemic Preparedness 47 Misleading Advertising 47 Prompts Debate 47 Lobbying Efforts 47 Official Urges 47 Legislation Introduced 47 Community Acquired Pneumonia 47 Horizon Scanning 47 Could Undermine 47 Political Instability 47 Social Mobilisation 47 Psychiatric Disorders 47 Whitepaper 47 Mitigation Strategies 47 Causes Consequences 47 Ezulwini Consensus 47 Electronic Submission 47 Procedure 47 Expert Predicts 47 Long Term Outcomes 47 Sees Progress 47 Empirical Analysis 47 Post Menopausal 47 Antimalarial 47 Liver Toxicity 47 Reporting Requirements 47 Antibiotic Treatment 47 Actions Needed 47 Rules Eased 47 Umbilical Cord 47 Import Restrictions 47 Draws Mixed Reactions 47 Envoy Urges 47 Antimicrobials 47 Sleep Duration 47 Worksite Enforcement 47 Clinical Trial Enrollment 47 Gone Awry 47 Observational Studies 47 Impacts Adaptation 47 Novel Approach 47 journal Langmuir 47 Therapeutic Agents 47 Human Rights JCHR 47 Report Examines 47 Gene Variation 47 Statement EIS 47 Cervical Cancer Vaccine 47 Infertility Treatments 47 Makes Strides 47 Second Administrative Reforms 47 Advocates Urge 47 Protecting Intellectual Property 47 Renews Debate 47 Critical Success Factors 47 Maternal Deaths 47 Psychiatry #:#-# [002] 47 Ministerial Meetings 47 Globally Harmonized System 47 Osteoporosis Treatment 47 Cervical Cancer Detection 47 Falsify 47 Reaffirm Commitment 47 Osteoporosis Drug 47 Acne Drug 47 Foodborne Pathogens 47 Expert Warns 47 Needs Urgent 47 Provisional Regulations 47 Gender Roles 47 Debate Intensifies 47 Unapproved Drugs 47 Stakeholders Consultation 47 Operational Guidelines 47 Milbank Quarterly 47 Stalemate Continues 47 IGWG 47 Study Casts Doubt 47 Eco Label 47 Regulatory Submissions 47 Cost Effectiveness 47 Best Practices Guidelines 47 Groups Urge 47 Traditional Herbal 47 #/#/EEC [001] 47 Socioeconomic Status 47 Assessment Framework 47 Medicines CSM 47 Indian Pharmacopoeia 47 False Promise 47 Solvency II Directive 47 Too Costly 47 Peaceful Resolution 47 Imaging Technique 47 Self Defeating 47 Be Studied 47 Watchdog Urges 47 Efficacy Study 47 Clamping Down 47 Provide Clues 47 CESCR 47 Unique Challenges 47 PennyStockBets.com employees 47 Therapy Improves 47 Petronella Sibeene 47 Psychiatric Diagnosis 47 FDA Warns Against 47 Fundamentally Flawed 47 Tighter Controls 47 Moral Issue